Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/10841
Full metadata record
DC FieldValueLanguage
dc.contributor.authorYeoh, Bernard S Ken
dc.contributor.authorTaylor, David McDen
dc.contributor.authorTaylor, Simone Een
dc.date.accessioned2015-05-16T00:25:08Z
dc.date.available2015-05-16T00:25:08Z
dc.date.issued2009-06-01en
dc.identifier.citationEmergency Medicine Australasia : EMA; 21(3): 178-83en
dc.identifier.govdoc19527276en
dc.identifier.otherPUBMEDen
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/10841en
dc.description.abstractWe aimed to evaluate a multifaceted education initiative designed to reduce the prophylactic use of metoclopramide.This was a pre- and post-intervention trial undertaken in a single ED. All ED doctors and nurses were targeted. The intervention comprised a specifically designed, 19-slide 'e-learning module', accessible via the ED intranet, supplemented by in-service training and a range of reminder techniques (posters, emails and drug room flyers). The primary end-point was the proportion of patients administered metoclopramide prophylactically with their initial morphine dose. Data were collected on random samples of patients who received morphine, using explicit medical chart review.Both pre- and post-intervention periods were of 3 month duration. The charts of 146 cases were reviewed in each period. In the post-intervention period: * The proportion of patients administered metoclopramide prophylactically decreased from 22.6% to 4.1% (difference 18.5% [95% CI 10.3-26.7], P < 0.001) * The proportion of patients administered metoclopramide appropriately (for known morphine sensitivity, established nausea and rescue anti-emesis) rose marginally from 28.8% to 32.9% (difference 4.1% [95% CI -7.2-15.4], P = 0.53) * There was a 12.7% decrease in the number of ampoules of metoclopramide issued to the ED without a concurrent rise in the issue of other anti-emetic drugsThe education initiative resulted in a significant improvement in the evidence-based use of metoclopramide.en
dc.language.isoenen
dc.subject.otherAcute Diseaseen
dc.subject.otherAnalgesics, Opioid.adverse effects.therapeutic useen
dc.subject.otherAntiemetics.administration & dosageen
dc.subject.otherChi-Square Distributionen
dc.subject.otherEmergency Medicine.educationen
dc.subject.otherEmergency Service, Hospital.organization & administrationen
dc.subject.otherEvidence-Based Medicineen
dc.subject.otherFemaleen
dc.subject.otherHumansen
dc.subject.otherInservice Trainingen
dc.subject.otherIntervention Studiesen
dc.subject.otherMaleen
dc.subject.otherMetoclopramide.administration & dosageen
dc.subject.otherMiddle Ageden
dc.subject.otherMorphine.administration & dosage.therapeutic useen
dc.subject.otherPain.drug therapyen
dc.subject.otherTreatment Outcomeen
dc.titleEducation initiative improves the evidence-based use of metoclopramide following morphine administration in the emergency department.en
dc.typeJournal Articleen
dc.identifier.journaltitleEmergency Medicine Australasia : EMAen
dc.identifier.affiliationAustin Health, Heidelberg, Victoria, Australiaen
dc.identifier.doi10.1111/j.1742-6723.2009.01179.xen
dc.description.pages178-83en
dc.relation.urlhttps://pubmed.ncbi.nlm.nih.gov/19527276en
dc.type.austinJournal Articleen
local.name.researcherTaylor, David McD
item.openairetypeJournal Article-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.grantfulltextnone-
item.fulltextNo Fulltext-
item.cerifentitytypePublications-
item.languageiso639-1en-
crisitem.author.deptEmergency-
crisitem.author.deptPharmacy-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

14
checked on Mar 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.